NIAID Launched Program Targeting Hantaviruses Before Outbreak

Written by Jon Fleetwood

A massive National Institute of Allergy and Infectious Diseases (NIAID) pandemic-preparedness program focused in part on hantaviruses was already actively underway—and had just achieved unprecedented structural and vaccine-platform mapping of Andes hantavirus—before the highly publicized 2026 international Andes hantavirus outbreak ordeal emerged

Continue Reading No Comments

‘6G Dominance’ Bill Introduced Despite Mounting Concerns

Written by Jon Fleetwood

Congress has introduced legislation laying the groundwork for the next generation of global wireless infrastructure, openly directing the federal government to pursue “6G technology dominance” while integrating artificial intelligence systems, low-earth-orbit satellite networks, and worldwide telecommunications architecture into a centralized international strategy

Continue Reading 2 Comments

Moderna Confirms New Flu Shot Causes Six Times More Severe Reactions

Written by Jon Fleetwood

A newly published New England Journal of Medicine Phase 3 trial has confirmed that Moderna’s experimental mRNA seasonal influenza vaccine, mRNA-1010, caused severe short-term reactions at roughly six times the rate of standard-dose flu shots while delivering less than a 1-percentage-point absolute reduction in symptomatic, PCR-confirmed influenza-like illness

Continue Reading 1 Comment